317
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Effect of the Short-Term Use of Fluoroquinolone and β-Lactam Antibiotics on Mouse Gut Microbiota

, , , , , , ORCID Icon, & show all
Pages 4547-4558 | Published online: 21 Dec 2020

References

  • Tan SY, Tatsumura Y. Alexander Fleming (1881–1955): discoverer of penicillin. Singapore Med J. 2015;56(7):366–367. doi:10.11622/smedj.201510526243971
  • Gajdács M. The Concept of an Ideal Antibiotic: implications for Drug Design. Molecules. 2019;24(5):5. doi:10.3390/molecules24050892
  • Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol. 2013;13(11):790–801.24096337
  • Gu S, Chen Y, Wu Z, et al. Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza. Clin Infect Dis. 2020.
  • Tang L, Gu S, Gong Y, et al. Clinical Significance of the Correlation between Changes in the Major Intestinal Bacteria Species and COVID-19 Severity. Engineering. 2020.
  • Feng Y, Ling Y, Bai T, et al. COVID-19 with Different Severities: A Multicenter Study of Clinical Features. Am J Respir Crit Care Med. 2020;201(11):1380–1388.32275452
  • Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4554–4561.20847294
  • Sharon G, Sampson TR, Geschwind DH, Mazmanian SK. The Central Nervous System and the Gut Microbiome. Cell. 2016;167(4):915–932.27814521
  • Takiishi T, Fenero CIM, Camara NOS. Intestinal barrier and gut microbiota: shaping our immune responses throughout life. Tissue Barriers. 2017;5(4):e1373208.28956703
  • Diehl GE, Longman RS, Zhang J-X, et al. Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX3CR1hi cells. Nature. 2013;494(7435):116–120. doi:10.1038/nature1180923334413
  • Wingender G, Stepniak D, Krebs P, et al. Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice. Gastroenterology. 2012;143(2):418–428. doi:10.1053/j.gastro.2012.04.01722522092
  • Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol. 2017;14(10):573–584.28743984
  • Arrieta M-C, Stiemsma LT, Dimitriu PA, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med. 2015;7(307):307ra152. doi:10.1126/scitranslmed.aab2271
  • Azad MB, Bridgman SL, Becker AB, Kozyrskyj AL. Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int j Obesity. 2014;38(10):1290–1298. doi:10.1038/ijo.2014.119
  • Dethlefsen L, Huse S, Sogin ML, Relman DA, Eisen JA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008;6(11):e280. doi:10.1371/journal.pbio.006028019018661
  • Chang JY, Antonopoulos DA, Kalra A, et al. Decreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile –Associated Diarrhea. J Infect Dis. 2008;197(3):435–438. doi:10.1086/52504718199029
  • Urbán E, Terhes G, Extraintestinal GM. Clostridioides difficile Infections: epidemiology in a University Hospital in Hungary and Review of the Literature. Antibiotics. 2020;9:1.
  • Ubeda C, Pamer EG. Antibiotics, microbiota, and immune defense. Trends Immunol. 2012;33(9):459–466. doi:10.1016/j.it.2012.05.00322677185
  • Candon S, Perez-Arroyo A, Marquet C, et al. Correction: antibiotics in Early Life Alter the Gut Microbiome and Increase Disease Incidence in a Spontaneous Mouse Model of Autoimmune Insulin-Dependent Diabetes. PLoS One. 2016;11(1):e0147888. doi:10.1371/journal.pone.014788826799316
  • Ho J, Ip IM. Antibiotic-Resistant Community-Acquired Bacterial Pneumonia. Infect Dis Clin North Am. 2019;33(4):1087–1103. doi:10.1016/j.idc.2019.07.00231668192
  • Pultz NJ, Donskey CJ. Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice. Antimicrob Agents Chemother. 2005;49(8):3529–3532. doi:10.1128/AAC.49.8.3529-3532.200516048976
  • Gajdács M, Spengler G, Urbán E. Identification and Antimicrobial Susceptibility Testing of Anaerobic Bacteria: rubik’s Cube of Clinical Microbiology? Antibiotics. 2017;6:4.
  • National Research Council Committee for the Update of the Guide for the C, Use of Laboratory A. The National Academies Collection: Reports Funded by National Institutes of Health. In: Guide for the Care and Use of Laboratory Animals. Washington (DC): National Academies Press (US) Copyright © 2011. National Academy of Sciences; 2011.
  • Gu S, Chen Y, Zhang X, et al. Identification of key taxa that favor intestinal colonization of Clostridium difficile in an adult Chinese population. Microbes Infect. 2016;18(1):30–38. doi:10.1016/j.micinf.2015.09.00826383014
  • Kc N. A brief history of antibiotics and select advances in their synthesis. J Antibiotics. 2018;71(2):153–184.
  • Benkő R, Gajdács M, Matuz M, et al. Prevalence and Antibiotic Resistance of ESKAPE Pathogens Isolated in the Emergency Department of a Tertiary Care Teaching Hospital in Hungary: A 5-Year Retrospective Survey. Antibiotics. 2020;9:9.
  • Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell. 2012;148(6):1258–1270. doi:10.1016/j.cell.2012.01.03522424233
  • Korpela K, Salonen A, Virta LJ, et al. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat Commun. 2016;7(1):10410. doi:10.1038/ncomms1041026811868
  • Tan SY. Alexander Fleming (1881–1955): discoverer of penicillin. Singapore Medical Journal. 2013;494(7435):463–466. doi:10.1016/j.explore.2016.08.015
  • Sanders ME. Probiotics: definition, sources, selection, and uses. Clin Infect Dis. 2008;46(Suppl 2):S58–S61.18181724
  • Hammad AM, Shimamoto T. Towards a compatible probiotic-antibiotic combination therapy: assessment of antimicrobial resistance in the Japanese probiotics. J Appl Microbiol. 2010;109(4):1349–1360.20497275
  • Hugenholtz F, de Vos WM. Mouse models for human intestinal microbiota research: a critical evaluation. Cell Mol Life Sci. 2018;75(1):149–160.29124307
  • Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun. 2009;77(6):2367–2375.19307217
  • Semenitz E. [Mechanism of action of beta-lactam antibiotics and problems concerning the development of resistance in antibacterial chemotherapy]. Wien Klin Wochenschr Suppl. 1983;142:7–11.6606272
  • Nakano V. Antimicrobial resistance and prevalence of resistance genes in intestinal Bacteroidales strains. Clinics. 2011;66(4):543–547.21655744
  • Wrzosek L, Miquel S, Noordine ML, et al. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 2013;11:61.23692866
  • Faber F, Tran L, Byndloss MX, et al. Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion. Nature. 2016;534(7609):697–699.27309805
  • Lu S, Huang Q, Wei B, Chen Y. Effects of β-Lactam Antibiotics on Gut Microbiota Colonization and Metabolites in Late Preterm Infants. Curr Microbiol. 2020.
  • Fiore E, Van Tyne D, Gilmore MS. Pathogenicity of Enterococci. Microbiology Spectrum. 2019;7:4.
  • Britton RA, Young VB. Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology. 2014;146(6):1547–1553.24503131
  • Reeves AE, Theriot CM, Bergin IL, Huffnagle GB, Schloss PD, Young VB. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection. Gut Microbes. 2011;2(3):145–158.21804357
  • Vardakas KZ, Trigkidis KK, Boukouvala E, Falagas ME. Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis. Int J Antimicrob Agents. 2016;48(1):1–10.27216385
  • Elshaer D, Begun J. The role of barrier function, autophagy, and cytokines in maintaining intestinal homeostasis. Semin Cell Dev Biol. 2017;61:51–59.27565684
  • Kim HJ, Li H, Collins JJ, Ingber DE. Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc Natl Acad Sci U S A. 2016;113(1):E7–15.26668389
  • Ferrer M. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut Microbes. 2014;5(1):64–70.24418972
  • Croom KF, Goa KL. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States. Drugs. 2003;63(24):2769–2802.14664657